The studies evaluated the tissue distribution and pharmacokinetics of indium-111-edotreotide in two animal models. One study included in vitro studies and evaluated another potential imaging surrogate, indium-111-pentetreotide (Octreotide).
Under the terms of the collaboration, Kyowa Hakko will pay Alnylam $15 million in an upfront cash payment and up to an additional $78 million in development and
AcnEase is a proprietary herbal formula based on principles of traditional Chinese medicine and a modern herbaceutical science that is used for improving conditions associated with acne and
With the FDA CLIA waiver, non-laboratory trained physicians and other health care professionals in any health care facility with a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver
The committee reviewed data from one of the largest biologic clinical programs in psoriasis, which included two large Phase III multicenter, randomized, double-blind, placebo-controlled trials evaluating the safety
Most recently, Ms DeFilippo served as CFO and vice president of business development for the Guidant Cardiac Surgery business. Wick Goodspeed, president and CEO of FlowCardia, said: “Deborah
The pretargeted therapy involved TF10, a humanized bispecific antibody that binds to the same pancreatic cancer mucin as the antibody PAM4. TF10 was created by the company’s protein
Under conditions of the merger agreement, PacificGMP will receive funds to expand its operation in San Diego and assist in the development of the Taizhou facility and preparations
The Phase I trial is designed to assess the safety, tolerability and pharmacokinetics, as well as preliminary antitumor activity of TRC102 in patients with advanced cancer who also
Poly-ICR is a Toll-like Receptor 3 (TLR3) agonist that when combined with a disease-specific antigen can induce both cytotoxic (T-cell) and antibody (B-cell) immune responses against that antigen.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.